ERBB2 and breast carcinoma: We utilized summary statistics from a large genome‐wide association study (GWAS) on meningiomas, HER2‐positive breast cancer, HER2‐negative breast cancer, and overall breast cancer to conduct a two‐sample MR analysis in this investigation.